StonvexLoading…
StonvexStonvexStonvexCore line items from AVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-28 | Annual 2024 2024-06-29 | Annual 2023 2023-07-01 | Annual 2022 2022-07-02 |
|---|---|---|---|---|
Revenue | $22.20B | $23.76B | $26.54B | $24.31B |
Operating Income | $514.25M | $844.37M | $1.19B | $939.01M |
Net Income | $240.22M | $498.70M | $770.83M | $692.38M |
EPS (Diluted) | $2.75 | $5.43 | $8.26 | $6.94 |
Total Assets | $12.12B | $12.21B | $12.48B | $10.39B |
Total Liabilities | $7.11B | $7.28B | $7.73B | $6.20B |
Cash & Equivalents | $192.43M | $310.94M | $288.23M | $153.69M |
Free Cash Flow OCF − CapEx | $577.03M | $463.51M | $-908.38M | $-268.21M |
Shares Outstanding | 87.41M | 91.84M | 93.37M | 99.82M |